Cargando…
The role of CD26 and CD40 expression in therapeutic response - experimental study in oral cancer lines
Autores principales: | Batista, Joana PN, Neves, Sílvia S, Gonçalves, A Cristina, Alves, Vera, Sarmento-Ribeiro, Ana, Dourado, Marília |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255070/ |
Ejemplares similares
-
New targeted therapies in myelodysplastic syndrome: the role of farnesyltransferase and proteasome inhibitors
por: Gonçalves, A Cristina, et al.
Publicado: (2010) -
Histone deacetylation - a new epigenetic target in cancer
por: Carvalho, João A, et al.
Publicado: (2010) -
Multimeric forms of CD40 ligand (CD40L), 4-1BB ligand (4-1BBL), OX40 ligand (OX40L), CD27L/CD70, and other TNFSFs as tools for adoptive cell therapy
por: Kornbluth, Richard S
Publicado: (2013) -
The CD40–CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
por: Aarts, Suzanne A. B. M., et al.
Publicado: (2017) -
Recombinant trail: a synergistic effect in myeloid leukemias
por: Carvalho, Filipa, et al.
Publicado: (2010)